Dr. Rickels also asserts his belief that alternative strategies, such as multiple raters or active placebos, will not be effective in preserving the blind. Certainly, one size does not fit all in a clinical trial design. However, given that existing trial design guidelines advocate these strategies, we might hope for an empirical study before dismissing them out of hand.